TLR2 and melanoma: Indeed TLR2 activation with bacterial lipoproteins in MDSCs supports cancer growth by promoting MDSC survival, accumulation, and recruitment to the tumor microenvironment in mouse lymphoma, melanoma, lung cancer, fibrosarcoma, and CRC models and is verified to be correlated with worse prognosis in human CRC tissues (45–47).